Event details from: Seminar by: Karmella A. Haynes, PhD

Date
7 October 2024
Time
15:00 – 16:00
Room
L1.13

Protein-protein interactions between transcriptional regulators, known as 'reader-effectors,' and their targets, modified histones or methylated DNA, are crucial for interpreting chromatin marks encoding differential expression programs. Our lab developed a synthetic biology approach, 'epigenome actuation,' using a rational design to build synthetic reader-actuator (SRA) fusion proteins using the ‘build, test and learn’ method to interpret reader-effector functionality. In this talk, I’ll describe the development of the first SRA, Polycomb-based transcription factor (PcTF), which reads the histone H3 lysine 27 trimethylation (H3K27me3) modification and activates transcription via a strong transcriptional activator (4x-VP16) domain. We demonstrated a practical use of this SRA to restore transcription in chemo-resistant triple negative breast cancer cells at tumor suppressor genes that had become hyper repressed by H3K27me3 and Polycomb complexes. SRA expression increased the expression of multiple genes including cell-cycle arrest and apoptotic genes and blocked spheroid growth and Matrigel invasion in vitro. Additionally, we investigated how these SRAs regulate H3K27me3-enriched domains in estrogen receptor positive (ER+) breast cancer MCF7 cells, uncovering new insights into chromatin domain organization within TADs. These findings have exciting implications for transcriptional control across genomic regions based on chromatin marks.